Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 14 | 2017 | 219 | 1.960 |
Why?
|
Image Processing, Computer-Assisted | 19 | 2023 | 689 | 1.750 |
Why?
|
Brain Neoplasms | 14 | 2018 | 371 | 1.690 |
Why?
|
Machine Learning | 12 | 2023 | 170 | 1.640 |
Why?
|
Magnetic Resonance Imaging | 18 | 2019 | 2222 | 1.430 |
Why?
|
Skin Neoplasms | 9 | 2022 | 375 | 1.400 |
Why?
|
Dermoscopy | 6 | 2022 | 14 | 1.250 |
Why?
|
Brain | 9 | 2019 | 2176 | 1.070 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 5 | 2010 | 24 | 1.050 |
Why?
|
Diffusion Tensor Imaging | 8 | 2015 | 211 | 1.040 |
Why?
|
Alzheimer Disease | 3 | 2023 | 565 | 1.020 |
Why?
|
Pyrimidines | 5 | 2010 | 178 | 0.960 |
Why?
|
Software | 6 | 2020 | 418 | 0.950 |
Why?
|
Neural Pathways | 7 | 2015 | 323 | 0.940 |
Why?
|
Brain Mapping | 9 | 2015 | 531 | 0.910 |
Why?
|
Genomics | 10 | 2019 | 168 | 0.890 |
Why?
|
Image Interpretation, Computer-Assisted | 10 | 2020 | 237 | 0.890 |
Why?
|
Nerve Block | 2 | 2019 | 55 | 0.810 |
Why?
|
Lymphangioma, Cystic | 1 | 2021 | 3 | 0.760 |
Why?
|
Airway Obstruction | 1 | 2021 | 49 | 0.730 |
Why?
|
Emergence Delirium | 1 | 2020 | 4 | 0.730 |
Why?
|
Workplace Violence | 1 | 2020 | 8 | 0.720 |
Why?
|
Physostigmine | 1 | 2020 | 14 | 0.720 |
Why?
|
Melanoma | 6 | 2022 | 335 | 0.710 |
Why?
|
Myotomy | 1 | 2019 | 14 | 0.700 |
Why?
|
Nervous System | 1 | 2019 | 45 | 0.690 |
Why?
|
Esophageal Achalasia | 1 | 2019 | 78 | 0.670 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 102 | 0.660 |
Why?
|
Database Management Systems | 2 | 2016 | 25 | 0.650 |
Why?
|
Decision Support Systems, Clinical | 2 | 2019 | 88 | 0.650 |
Why?
|
Dogs | 1 | 2019 | 490 | 0.640 |
Why?
|
Neoplasms | 5 | 2020 | 1664 | 0.640 |
Why?
|
Medical Informatics | 2 | 2016 | 71 | 0.640 |
Why?
|
Pain, Postoperative | 2 | 2019 | 214 | 0.630 |
Why?
|
Libraries, Digital | 1 | 2017 | 2 | 0.620 |
Why?
|
Databases, Factual | 5 | 2016 | 621 | 0.600 |
Why?
|
Humans | 70 | 2023 | 68549 | 0.600 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2017 | 75 | 0.540 |
Why?
|
Behavior, Animal | 5 | 2019 | 470 | 0.510 |
Why?
|
Reproducibility of Results | 10 | 2022 | 2077 | 0.490 |
Why?
|
Data Collection | 1 | 2016 | 420 | 0.490 |
Why?
|
Atlases as Topic | 2 | 2013 | 5 | 0.480 |
Why?
|
Anti-Anxiety Agents | 3 | 2010 | 107 | 0.470 |
Why?
|
Algorithms | 9 | 2020 | 1195 | 0.470 |
Why?
|
Biomarkers, Tumor | 8 | 2018 | 508 | 0.470 |
Why?
|
Biomedical Research | 2 | 2020 | 310 | 0.460 |
Why?
|
Internet | 4 | 2019 | 390 | 0.460 |
Why?
|
Neoplasm Proteins | 2 | 2015 | 307 | 0.460 |
Why?
|
Glioma | 5 | 2018 | 140 | 0.450 |
Why?
|
Pathology, Clinical | 1 | 2013 | 16 | 0.450 |
Why?
|
Artificial Intelligence | 4 | 2022 | 159 | 0.430 |
Why?
|
Gyrus Cinguli | 3 | 2012 | 113 | 0.430 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2014 | 239 | 0.420 |
Why?
|
Olfactory Pathways | 1 | 2012 | 9 | 0.420 |
Why?
|
Manganese Compounds | 1 | 2012 | 8 | 0.420 |
Why?
|
Chlorides | 1 | 2012 | 68 | 0.420 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 848 | 0.410 |
Why?
|
Deep Brain Stimulation | 2 | 2012 | 71 | 0.400 |
Why?
|
Reflex, Startle | 2 | 2012 | 39 | 0.390 |
Why?
|
Contrast Media | 4 | 2014 | 595 | 0.390 |
Why?
|
Crowdsourcing | 2 | 2022 | 8 | 0.380 |
Why?
|
Computer Simulation | 3 | 2013 | 706 | 0.380 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2013 | 51 | 0.380 |
Why?
|
Male | 32 | 2022 | 37283 | 0.370 |
Why?
|
Female | 33 | 2022 | 38021 | 0.370 |
Why?
|
Histological Techniques | 3 | 2019 | 10 | 0.360 |
Why?
|
Internal Capsule | 1 | 2008 | 7 | 0.330 |
Why?
|
Hydrocortisone | 3 | 2013 | 291 | 0.330 |
Why?
|
Swimming | 1 | 2008 | 38 | 0.320 |
Why?
|
Social Behavior | 3 | 2015 | 164 | 0.320 |
Why?
|
Prognosis | 10 | 2020 | 2093 | 0.310 |
Why?
|
Skin | 4 | 2021 | 451 | 0.310 |
Why?
|
Adult | 21 | 2021 | 21379 | 0.310 |
Why?
|
Fear | 3 | 2014 | 239 | 0.290 |
Why?
|
White Matter | 3 | 2014 | 174 | 0.290 |
Why?
|
Breast Neoplasms | 4 | 2022 | 1533 | 0.290 |
Why?
|
Animals | 18 | 2019 | 20880 | 0.290 |
Why?
|
Motor Activity | 2 | 2018 | 621 | 0.280 |
Why?
|
Amyloid beta-Peptides | 2 | 2020 | 191 | 0.280 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2006 | 21 | 0.270 |
Why?
|
Cerebral Cortex | 4 | 2013 | 415 | 0.260 |
Why?
|
Datasets as Topic | 4 | 2020 | 52 | 0.260 |
Why?
|
Doxapram | 1 | 2005 | 2 | 0.260 |
Why?
|
Breeding | 2 | 2019 | 15 | 0.260 |
Why?
|
Cell Nucleus | 3 | 2022 | 305 | 0.250 |
Why?
|
Depressive Disorder | 1 | 2008 | 621 | 0.240 |
Why?
|
Panic Disorder | 1 | 2005 | 121 | 0.240 |
Why?
|
Middle Aged | 15 | 2019 | 21119 | 0.240 |
Why?
|
Stress, Psychological | 3 | 2013 | 824 | 0.230 |
Why?
|
Genome, Human | 2 | 2014 | 62 | 0.230 |
Why?
|
Nevus | 3 | 2019 | 17 | 0.230 |
Why?
|
Morphine | 2 | 2018 | 76 | 0.230 |
Why?
|
Young Adult | 10 | 2021 | 5710 | 0.220 |
Why?
|
Endocrine System | 1 | 2003 | 11 | 0.220 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 627 | 0.220 |
Why?
|
Central Nervous System Stimulants | 1 | 2005 | 221 | 0.210 |
Why?
|
Stress, Physiological | 2 | 2007 | 215 | 0.210 |
Why?
|
Mutation | 4 | 2016 | 1213 | 0.210 |
Why?
|
Bone Marrow | 1 | 2023 | 168 | 0.210 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2014 | 1506 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 7 | 2010 | 2083 | 0.200 |
Why?
|
Social Environment | 1 | 2003 | 182 | 0.200 |
Why?
|
Hippocampus | 3 | 2014 | 471 | 0.200 |
Why?
|
Dermatologists | 2 | 2019 | 5 | 0.200 |
Why?
|
Psychomotor Performance | 2 | 2013 | 213 | 0.200 |
Why?
|
Nerve Net | 2 | 2019 | 180 | 0.190 |
Why?
|
Species Specificity | 2 | 2019 | 302 | 0.190 |
Why?
|
Allografts | 1 | 2021 | 63 | 0.190 |
Why?
|
Uterus | 1 | 2021 | 77 | 0.190 |
Why?
|
Workflow | 2 | 2023 | 100 | 0.180 |
Why?
|
Attention | 2 | 2013 | 225 | 0.180 |
Why?
|
TDP-43 Proteinopathies | 1 | 2020 | 1 | 0.180 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 1753 | 0.180 |
Why?
|
Lewy Body Disease | 1 | 2020 | 9 | 0.180 |
Why?
|
Pan troglodytes | 3 | 2014 | 6 | 0.180 |
Why?
|
Cesarean Section | 1 | 2021 | 101 | 0.180 |
Why?
|
Gene Expression Profiling | 5 | 2016 | 498 | 0.180 |
Why?
|
Dermatology | 1 | 2022 | 75 | 0.180 |
Why?
|
Rats | 8 | 2014 | 5300 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 7 | 0.180 |
Why?
|
Predatory Behavior | 1 | 2019 | 10 | 0.170 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2019 | 24 | 0.170 |
Why?
|
Pathology | 1 | 2019 | 17 | 0.170 |
Why?
|
STAT1 Transcription Factor | 1 | 2019 | 35 | 0.170 |
Why?
|
Gestational Age | 1 | 2021 | 389 | 0.170 |
Why?
|
Pigmentation Disorders | 1 | 2019 | 11 | 0.170 |
Why?
|
Body Size | 1 | 2019 | 39 | 0.170 |
Why?
|
Skull | 1 | 2019 | 63 | 0.170 |
Why?
|
Computational Biology | 2 | 2011 | 190 | 0.170 |
Why?
|
Maze Learning | 2 | 2010 | 138 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 786 | 0.170 |
Why?
|
Organ Size | 1 | 2019 | 242 | 0.170 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 300 | 0.170 |
Why?
|
Aged | 7 | 2017 | 14842 | 0.160 |
Why?
|
Models, Statistical | 3 | 2012 | 448 | 0.160 |
Why?
|
Labor Pain | 1 | 2018 | 1 | 0.160 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 217 | 0.160 |
Why?
|
Cesarean Section, Repeat | 1 | 2018 | 4 | 0.160 |
Why?
|
Phylogeny | 1 | 2019 | 196 | 0.160 |
Why?
|
Genes, Neoplasm | 2 | 2016 | 18 | 0.160 |
Why?
|
Sentinel Lymph Node | 1 | 2018 | 4 | 0.160 |
Why?
|
Anesthesia, Obstetrical | 1 | 2018 | 11 | 0.160 |
Why?
|
Interferon-gamma | 1 | 2019 | 241 | 0.160 |
Why?
|
Genetic Variation | 1 | 2019 | 220 | 0.160 |
Why?
|
Anesthesia, Spinal | 1 | 2018 | 16 | 0.160 |
Why?
|
Analgesia, Obstetrical | 1 | 2018 | 15 | 0.160 |
Why?
|
Smell | 1 | 2019 | 131 | 0.160 |
Why?
|
Genetic Markers | 2 | 2015 | 144 | 0.160 |
Why?
|
Bupivacaine | 1 | 2018 | 27 | 0.160 |
Why?
|
Epinephrine | 1 | 2018 | 103 | 0.160 |
Why?
|
Survival Analysis | 6 | 2016 | 714 | 0.160 |
Why?
|
Patient Safety | 1 | 2020 | 202 | 0.160 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 91 | 0.150 |
Why?
|
Microvessels | 2 | 2017 | 43 | 0.150 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 33 | 0.150 |
Why?
|
Lentigo | 1 | 2017 | 4 | 0.150 |
Why?
|
Survival | 1 | 2017 | 22 | 0.150 |
Why?
|
Image Enhancement | 2 | 2015 | 143 | 0.150 |
Why?
|
Mental Disorders | 1 | 2003 | 659 | 0.150 |
Why?
|
Phenotype | 6 | 2016 | 946 | 0.150 |
Why?
|
Pregnancy | 2 | 2021 | 2334 | 0.150 |
Why?
|
Anesthetics, Local | 1 | 2018 | 83 | 0.150 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 2791 | 0.150 |
Why?
|
Parietal Lobe | 2 | 2014 | 59 | 0.150 |
Why?
|
Treatment Outcome | 6 | 2019 | 7028 | 0.150 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2010 | 106 | 0.150 |
Why?
|
Proportional Hazards Models | 3 | 2014 | 791 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 333 | 0.140 |
Why?
|
Frontal Lobe | 2 | 2014 | 156 | 0.140 |
Why?
|
Survival Rate | 3 | 2014 | 1055 | 0.140 |
Why?
|
Kidney | 1 | 2021 | 945 | 0.140 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 94 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2019 | 756 | 0.130 |
Why?
|
DNA Methylation | 2 | 2016 | 193 | 0.130 |
Why?
|
Proteomics | 1 | 2017 | 246 | 0.130 |
Why?
|
Delivery of Health Care | 1 | 2020 | 445 | 0.130 |
Why?
|
Tumor Microenvironment | 2 | 2017 | 213 | 0.130 |
Why?
|
Geniculate Bodies | 1 | 2014 | 10 | 0.120 |
Why?
|
Genetic Techniques | 1 | 2015 | 32 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 444 | 0.120 |
Why?
|
Histocytochemistry | 1 | 2015 | 149 | 0.120 |
Why?
|
User-Computer Interface | 1 | 2016 | 230 | 0.120 |
Why?
|
Time Factors | 4 | 2018 | 4655 | 0.120 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 498 | 0.120 |
Why?
|
Anhedonia | 1 | 2014 | 15 | 0.120 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2014 | 3 | 0.120 |
Why?
|
Embolism | 1 | 2014 | 45 | 0.120 |
Why?
|
Infant | 1 | 2021 | 2891 | 0.120 |
Why?
|
Biological Evolution | 1 | 2014 | 86 | 0.120 |
Why?
|
Prevalence | 2 | 2015 | 1609 | 0.120 |
Why?
|
Social Dominance | 1 | 2013 | 4 | 0.120 |
Why?
|
Cell Death | 1 | 2014 | 329 | 0.120 |
Why?
|
Interpersonal Relations | 1 | 2015 | 209 | 0.110 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2007 | 435 | 0.110 |
Why?
|
Systems Integration | 1 | 2013 | 30 | 0.110 |
Why?
|
Gene Dosage | 1 | 2013 | 47 | 0.110 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2013 | 4 | 0.110 |
Why?
|
Lung Neoplasms | 1 | 2022 | 1172 | 0.110 |
Why?
|
Kidney Transplantation | 1 | 2021 | 839 | 0.110 |
Why?
|
Electronic Health Records | 1 | 2016 | 374 | 0.110 |
Why?
|
Imitative Behavior | 1 | 2012 | 4 | 0.110 |
Why?
|
Gene Expression | 2 | 2013 | 770 | 0.110 |
Why?
|
Brain Injuries | 1 | 2015 | 268 | 0.100 |
Why?
|
Amygdala | 1 | 2014 | 159 | 0.100 |
Why?
|
Movement | 1 | 2013 | 179 | 0.100 |
Why?
|
Cells | 1 | 2012 | 7 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 1465 | 0.100 |
Why?
|
Mice | 3 | 2014 | 8474 | 0.100 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 48 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2013 | 141 | 0.100 |
Why?
|
Decision Making | 1 | 2015 | 410 | 0.100 |
Why?
|
Models, Biological | 2 | 2014 | 981 | 0.100 |
Why?
|
Echo-Planar Imaging | 1 | 2011 | 17 | 0.100 |
Why?
|
Bias | 1 | 2012 | 148 | 0.100 |
Why?
|
Cell Count | 2 | 2023 | 248 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2010 | 46 | 0.090 |
Why?
|
Genotype | 4 | 2014 | 785 | 0.090 |
Why?
|
Septal Nuclei | 1 | 2010 | 31 | 0.090 |
Why?
|
Oligodendroglioma | 1 | 2010 | 18 | 0.090 |
Why?
|
Up-Regulation | 2 | 2012 | 682 | 0.090 |
Why?
|
Risk Factors | 3 | 2015 | 5720 | 0.090 |
Why?
|
Learning | 1 | 2012 | 186 | 0.090 |
Why?
|
Protein Binding | 2 | 2019 | 1027 | 0.090 |
Why?
|
Signal Transduction | 5 | 2019 | 2689 | 0.090 |
Why?
|
Disease Models, Animal | 2 | 2010 | 2550 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2014 | 4843 | 0.090 |
Why?
|
Megakaryocytes | 1 | 2009 | 18 | 0.090 |
Why?
|
Game Theory | 2 | 2015 | 7 | 0.090 |
Why?
|
G1 Phase | 1 | 2009 | 42 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2012 | 307 | 0.080 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2012 | 257 | 0.080 |
Why?
|
MicroRNAs | 2 | 2015 | 447 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2012 | 334 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2015 | 219 | 0.080 |
Why?
|
Prefrontal Cortex | 2 | 2012 | 639 | 0.080 |
Why?
|
Rats, Inbred Strains | 1 | 2008 | 532 | 0.080 |
Why?
|
Aging | 1 | 2014 | 911 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 137 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 2 | 2019 | 108 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2022 | 7268 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 231 | 0.080 |
Why?
|
ROC Curve | 2 | 2019 | 392 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 438 | 0.070 |
Why?
|
Exercise Test | 1 | 2008 | 242 | 0.070 |
Why?
|
United States | 2 | 2019 | 7338 | 0.070 |
Why?
|
Lorazepam | 1 | 2007 | 54 | 0.070 |
Why?
|
Adolescent | 3 | 2014 | 8904 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2007 | 96 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 2265 | 0.070 |
Why?
|
Biogenic Monoamines | 1 | 2006 | 18 | 0.070 |
Why?
|
Catecholamines | 1 | 2006 | 73 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2009 | 1034 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 447 | 0.060 |
Why?
|
Neoplasm Invasiveness | 2 | 2016 | 369 | 0.060 |
Why?
|
Cohort Studies | 2 | 2022 | 2356 | 0.060 |
Why?
|
Neuropsychological Tests | 3 | 2012 | 517 | 0.050 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2003 | 79 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2007 | 1851 | 0.050 |
Why?
|
Corticosterone | 1 | 2003 | 51 | 0.050 |
Why?
|
Macaca mulatta | 2 | 2013 | 76 | 0.050 |
Why?
|
Receptors, Dopamine D2 | 1 | 2003 | 109 | 0.050 |
Why?
|
Anisotropy | 2 | 2013 | 105 | 0.050 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 2002 | 41 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2003 | 79 | 0.050 |
Why?
|
Fibric Acids | 1 | 2022 | 12 | 0.050 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2002 | 59 | 0.050 |
Why?
|
Altruism | 1 | 2002 | 24 | 0.050 |
Why?
|
N-Methylaspartate | 1 | 2002 | 59 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2018 | 1174 | 0.050 |
Why?
|
Mood Disorders | 1 | 2003 | 132 | 0.050 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2002 | 75 | 0.050 |
Why?
|
Decision Trees | 1 | 2022 | 74 | 0.050 |
Why?
|
Limbic System | 1 | 2002 | 106 | 0.050 |
Why?
|
Photic Stimulation | 2 | 2012 | 229 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 536 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2003 | 216 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 236 | 0.050 |
Why?
|
Metadata | 1 | 2021 | 1 | 0.050 |
Why?
|
Checklist | 1 | 2022 | 76 | 0.050 |
Why?
|
Consensus | 1 | 2022 | 211 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 320 | 0.050 |
Why?
|
Sex Factors | 2 | 2014 | 1265 | 0.050 |
Why?
|
Reward | 1 | 2002 | 201 | 0.050 |
Why?
|
Surveys and Questionnaires | 2 | 2023 | 2798 | 0.050 |
Why?
|
Immunotherapy | 1 | 2022 | 215 | 0.050 |
Why?
|
Peptides | 1 | 2003 | 455 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2013 | 1040 | 0.040 |
Why?
|
Medical Oncology | 1 | 2020 | 110 | 0.040 |
Why?
|
Genes, MHC Class I | 1 | 2019 | 14 | 0.040 |
Why?
|
Genes, MHC Class II | 1 | 2019 | 29 | 0.040 |
Why?
|
Colombia | 1 | 2019 | 8 | 0.040 |
Why?
|
Keratosis, Seborrheic | 1 | 2019 | 2 | 0.040 |
Why?
|
Israel | 1 | 2019 | 26 | 0.040 |
Why?
|
Spain | 1 | 2019 | 34 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2012 | 782 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2019 | 76 | 0.040 |
Why?
|
International Cooperation | 1 | 2019 | 88 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2017 | 1663 | 0.040 |
Why?
|
Transcription Factors | 2 | 2014 | 753 | 0.040 |
Why?
|
Subarachnoid Space | 1 | 2018 | 7 | 0.040 |
Why?
|
New York City | 1 | 2018 | 49 | 0.040 |
Why?
|
Cognition | 1 | 2002 | 512 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2018 | 53 | 0.040 |
Why?
|
Pain Threshold | 1 | 2018 | 55 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2021 | 307 | 0.040 |
Why?
|
Aminolevulinic Acid | 1 | 2017 | 5 | 0.040 |
Why?
|
Margins of Excision | 1 | 2017 | 15 | 0.040 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2017 | 29 | 0.040 |
Why?
|
Binding Sites | 1 | 2019 | 631 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2017 | 32 | 0.040 |
Why?
|
Fluorescence | 1 | 2017 | 104 | 0.040 |
Why?
|
Genetic Association Studies | 1 | 2017 | 103 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 331 | 0.040 |
Why?
|
Paraventricular Hypothalamic Nucleus | 2 | 2007 | 15 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2017 | 85 | 0.040 |
Why?
|
Pain Measurement | 1 | 2018 | 328 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2016 | 52 | 0.040 |
Why?
|
Precision Medicine | 1 | 2018 | 111 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 331 | 0.040 |
Why?
|
Cerebrovascular Circulation | 2 | 2012 | 296 | 0.040 |
Why?
|
Anxiety | 2 | 2012 | 422 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2007 | 150 | 0.040 |
Why?
|
Pituitary-Adrenal System | 2 | 2007 | 138 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2016 | 142 | 0.030 |
Why?
|
Depression | 2 | 2014 | 942 | 0.030 |
Why?
|
ErbB Receptors | 1 | 2017 | 239 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 1140 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2017 | 307 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 700 | 0.030 |
Why?
|
Tumor Burden | 1 | 2015 | 132 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2015 | 45 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 82 | 0.030 |
Why?
|
Multimodal Imaging | 1 | 2015 | 62 | 0.030 |
Why?
|
Cell Cycle | 1 | 2016 | 312 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2019 | 1174 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2016 | 92 | 0.030 |
Why?
|
Dissection | 1 | 2014 | 29 | 0.030 |
Why?
|
Recovery of Function | 1 | 2018 | 506 | 0.030 |
Why?
|
Ependyma | 1 | 2014 | 1 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2017 | 384 | 0.030 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 5 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2018 | 1738 | 0.030 |
Why?
|
Microspheres | 1 | 2014 | 59 | 0.030 |
Why?
|
Radiography | 1 | 2015 | 572 | 0.030 |
Why?
|
Gray Matter | 1 | 2014 | 57 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2014 | 103 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2013 | 55 | 0.030 |
Why?
|
Internship and Residency | 1 | 2019 | 596 | 0.030 |
Why?
|
Functional Neuroimaging | 1 | 2013 | 82 | 0.030 |
Why?
|
Connectome | 1 | 2014 | 91 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 48 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 160 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2012 | 6 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 3 | 0.030 |
Why?
|
Alleles | 1 | 2013 | 386 | 0.030 |
Why?
|
Facial Expression | 1 | 2012 | 36 | 0.030 |
Why?
|
Electromyography | 1 | 2012 | 184 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2012 | 92 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2012 | 86 | 0.030 |
Why?
|
Emotions | 1 | 2013 | 244 | 0.020 |
Why?
|
Microscopy | 1 | 2011 | 64 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 239 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 249 | 0.020 |
Why?
|
Urban Population | 1 | 2012 | 254 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 1851 | 0.020 |
Why?
|
Rape | 1 | 2012 | 180 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 183 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2010 | 15 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 240 | 0.020 |
Why?
|
Extinction, Psychological | 1 | 2012 | 240 | 0.020 |
Why?
|
Prospective Studies | 1 | 2018 | 3703 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 852 | 0.020 |
Why?
|
Violence | 1 | 2012 | 275 | 0.020 |
Why?
|
Oxygen | 1 | 2012 | 386 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2012 | 562 | 0.020 |
Why?
|
Hemodynamics | 1 | 2012 | 705 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2009 | 4 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2009 | 8 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2009 | 15 | 0.020 |
Why?
|
Phorbol Esters | 1 | 2009 | 37 | 0.020 |
Why?
|
K562 Cells | 1 | 2009 | 44 | 0.020 |
Why?
|
Apoptosis | 1 | 2016 | 1641 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2009 | 75 | 0.020 |
Why?
|
Carcinogens | 1 | 2009 | 86 | 0.020 |
Why?
|
Mitochondria | 1 | 2014 | 643 | 0.020 |
Why?
|
Neurons | 2 | 2007 | 881 | 0.020 |
Why?
|
Macrophages | 1 | 2012 | 647 | 0.020 |
Why?
|
Risk Assessment | 1 | 2014 | 2004 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2009 | 268 | 0.020 |
Why?
|
RNA, Heterogeneous Nuclear | 1 | 2007 | 2 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 614 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2007 | 201 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 1070 | 0.020 |
Why?
|
Flumazenil | 1 | 2007 | 23 | 0.020 |
Why?
|
Child | 1 | 2014 | 6401 | 0.010 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 85 | 0.010 |
Why?
|
Cricetinae | 1 | 2003 | 262 | 0.010 |
Why?
|
Phosphatidylinositols | 1 | 2002 | 40 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2002 | 60 | 0.010 |
Why?
|
Hydrolysis | 1 | 2002 | 144 | 0.010 |
Why?
|
Electrophysiology | 1 | 2002 | 160 | 0.010 |
Why?
|
Receptor, Metabotropic Glutamate 5 | 1 | 2002 | 51 | 0.010 |
Why?
|
Oocytes | 1 | 2002 | 57 | 0.010 |
Why?
|
Ligands | 1 | 2003 | 317 | 0.010 |
Why?
|
Evoked Potentials | 1 | 2002 | 61 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 204 | 0.010 |
Why?
|
Reaction Time | 1 | 2002 | 170 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 1293 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2002 | 765 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2002 | 270 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 1082 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 1446 | 0.010 |
Why?
|
Dopamine | 1 | 2003 | 474 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 266 | 0.010 |
Why?
|
Nucleus Accumbens | 1 | 2003 | 417 | 0.010 |
Why?
|
Phosphorylation | 1 | 2002 | 1200 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2007 | 1242 | 0.010 |
Why?
|